Skip to content

Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'

Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05225467
Acronym
DKAP
Enrollment
58
Registered
2022-02-04
Start date
2022-03-15
Completion date
2023-03-18
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Keto Acidosis, Ketoses, Metabolic, Ketosis, Ketosis, Diabetic, Peri-operative

Keywords

Surgery, Ketones

Brief summary

Rationale: During perioperative period, prolonged starvation, surgical stress, acute complications (e.g. infection) and medication changes all promote ketone generation, therefore increasing the risk of ketoacidosis. At present, there is no literature concerning the ketone production in patients undergoing cardiac surgery, regardless of the diabetes status. Objectives: The objectives of this study are to explore the change in blood ketone level during the perioperative period in patients with and without diabetes, to observe the incidence of perioperative ketoacidosis, and to investigate therapy and outcome of patients with perioperative ketoacidosis.

Detailed description

Study procedures On the first day of admission, all the patients scheduled for cardiac surgery with an on-pump procedure will be asked for a consent for anonymous using of their information. Patients giving permission will be screened for participation in this study, and those fulfil the inclusion/exclusion criteria will be included for further research. Blood ketone will be measured with StatStrip Glucose/Ketone Meters (Nova biomedical, United Kingdom) using sample leftover from blood gas analysis. No extra blood draw is needed. The levels of ketones will be measured at four time points: 1. Beginning of surgery; 2. The moment the cardio-pulmonary bypass machine takes over the circulation. 3. After the decoupling of the Cardio-pulmonary bypass machine 4. At the end of surgery. Diagnosis of ketoacidosis is based on criteria mentioned. Epidemiology characteristics and perioperative variables will be extracted from electronic medical records.

Interventions

None listed

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria: Inclusion Criteria * Aged eighteen years or older * Scheduled for open heart surgery

Exclusion criteria

* Diagnosed with type 1 diabetes mellitus or latent auto-immune diabetes in adults * Recently used sodium glucose transport co-enzyme 2 (SGLT-2i's) within 2 weeks before surgery) * History of recurrent ketoacidosis (two times or more within three months) * Emergency surgery * (Suspected) pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Blood ketone differenceDuring surgeryThe primary outcome in this study is the difference in blood ketone level before and after cardiac surgery.

Secondary

MeasureTime frameDescription
Incidence of ketoacidosisPost surgery up to three daysThe diagnosis criteria for Ketoacidosis are: 1) Beta-hydroxybutyrate (BHB) ≥3 mmol/L or significant ketonuria (≥ ++); 2) blood glucose over 11 mmol/L; and 3) bicarbonate below 15 mmol or arterial potential of hydrogen(pH) less than 7.3.
Difference in ketone development between patient with and without diabetes mellitus.During SurgeryGlucose management is compared between two groups to see if there is a potential difference.

Other

MeasureTime frameDescription
OtherPost surgery up to three daysIncidence of hypoglycaemia

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026